Wang, Xia
Liu, Hong
Li, Ying
Su, Rui
Liu, Yamin
Qiao, Kunyan
Funding for this research was provided by:
the Key Project of Tianjin Second People’s Hospital (No.YS0019)
the 13th Five-year National Major Project for optimization of prevention and treatment plan for febrile rash syndrome based on HFMD (No.KY0112 2017ZX10103007-002)
Article History
Received: 13 April 2021
Accepted: 16 June 2021
First Online: 30 June 2021
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Medical Ethics Committee of Tianjin Second People’s Hospital (Approval Certificate of Ethical Review No. 201825).
: No consent for publication applicable. This manuscript does not provide any patients’ data nor any animal studies or experiments. This manuscript does not contain any individual person’s data in any form. The authors declare no financial and non-financial conflict of interests. This manuscript has not been submitted to, nor is under review at, another journal or other publishing venue. The authors have no affiliation with any organization with a direct or indirect financial interest in the subject matter discussed in the manuscript.
: The authors declare that they have no competing interests.